Beck, D. E. , Fennell, R. S., Yost, R. L., Robinson, J. D., Geary, D., & Richards, G. A. (1980). Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants. Journal of Pediatrics, 96, 1094-1097.
2.
Brooks, C. M. , Richards, J. M., Kohler, C. L., Soong, S. J., Martin, B., Windsor, R. A., & Bailey, W. C. (1994). Assessing adherence to asthma medication and inhalerregimens: Apsychometric analysis of adult self-report scales. Medical Care, 32, 298-307.
3.
Brownell, K. D. (1981). Assessment of eating disorders. In D. H. Barlow (Ed.), Behavioral assessment of adult disorders (pp. 329-404). New York: Guilford.
4.
Cheung, R. , Dickins, J., Nicholson, P. W., Thomas, A.S.C., Smith, H. H., Larson, H. E., Deshmukh, A. A., Dobbs, R. J., & Dobbs, S. M. (1988a). Compliance with anti-tuberculosis therapy: A field trial of a pill-box with a concealed electronic recording device. European Journal of Clinical Pharmacology, 35, 401-407.
5.
Cheung, R. , Sullens, C. M., Seal, D., Dickins, J., Nicholson, P. W., Deshmukh, A. A., Denham, M. J., & Dobbs, S. M. (1988b). The paradox of using a 7 day antibacterial course to treat urinary tract infections. British Journal of Clinical Pharmacology, 26, 391-398.
6.
Cramer, J. A. , Mattson, R. H., Prevey, M. L., Scheyer, R. D., & Ouellette, V. L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 261, 3273-3277.
7.
Cramer, J. A. , Scheyer, R. D., & Mattson, R. H. (1990). Compliance declines between clinic visits. Archives of Internal Medicine, 150, 1509-1510.
8.
De Geest, S. , Borgermans, L., Gemoets, H., Abraham, I., Vlaminck, H., Evers, G., & Vanrenterghem, Y (1995). Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation, 59, 340-347.
9.
Dew, M. A. , Roth, L. H., Thompson, M. E., Kormos, R. L., & Griffith, B. P. (1996). Medical compliance and its predictors in the first year after heart transplantation. Journal of Heart and Lung Transplantation, 15, 631-645.
10.
Dubbert, P. M. , King, A., Rapp, S. R., Brief, D., Martin, J. E., & Lake, M. (1985). Riboflavin as a tracer of medication compliance. Journal of Behavioral Medicine, 8, 287-299.
11.
Dunbar, J. (1984). Adherence measures and their utility. Controlled Clinical Trials, 5, 515-521.
12.
Erdman, R.A.M. , Horstman, L., van Domburg, R. T., Meeter, K., & Balk, A.H.H.M. (1993). Compliance with the medical regimen and partner's quality of life after heart transplantation. Quality of Life Research, 2, 205-212.
13.
Ettenger R. B. , Rosenthal, J. T., Marik, J. L., Malekzadeh, M., Forsythe, S. B., Kamil, E. S., Salusky, I. B., & Fine, R. N. (1991). Improved cadaveric renal transplant outcome in children. Pediatric Nephrology, 5(1), 137-142.
14.
Feinstein, A. R. (1990). On white-coat effects and the electronic monitoring of compliance. Archives of Internal Medicine, 150, 1377-1378.
15.
Fennell, R. S. , Foulkes, L. M., & Boggs, S. R. (1994). Family-based program to promote medication compliance in renal transplant children. Transplantation Proceedings, 26(1), 102-103.
16.
Gault, M. H. , Longerich, L. L., Vey, E. G., & Evans, E. M. (1993). Pharmacoeconomic comparison of cyclosporine oral solution and capsules afterkidney transplantation. Nephron, 65, 583-586.
17.
Haynes, R. B. (1979). Introduction. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care (pp. 1-7). Baltimore: John Hopkins University Press.
18.
Haynes, R. B. , Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D., & Mukherjee, J. (1980). Can simple clinical measurements detect patient noncompliance?Hypertension, 2, 757-764.
19.
Hilbert, G. (1985). Accuracy of self-reported measures of compliance. Nursing Research, 34, 319-320.
20.
Hilbrands, L. B. , Hoitsma, A. J., & Koene, R.A.P. (1995). Medication compliance after renal transplantation. Transplantation, 60, 914-920.
21.
Holt, D. W. , Fashola, O. A., & Johnston, A. (1991). Monitoring cyclosporine: Is it still important?Immunology Letters, 29, 99-104.
22.
Hong, J. H. , Sumrani, N., Delaney, V., Davis, R., Dibenedetto, A., & Butt, K.M.H. (1992). Causes of late renal allograft failure in the ciclosporin era. Nephron, 62, 272-279.
23.
Inui, T. S. , Carter, W. B., Pecoraro, R. E., Pearlman, R. A., & Dohan, J. J. (1980). Variations in patient compliance with common long-term drugs. Medical Care, 28, 986-993.
24.
Kruse, W. , Koch-Gwinner, P., Nikolaus, T., Oster, P., Schierf, G., & Weber, E. (1992). Measurement of drug compliance by continuous electronic monitoring: A pilot study in elderly patients discharged from hospital. Journal of the American Geriatrics Society, 40, 1151-1155.
25.
Kruse, W. , & Weber, E. (1990). Dynamics of drug regimen compliance: Its assessment by microprocessor-based monitoring. European Journal of Clinical Pharmacology, 38, 561-565.
26.
Lemaire, M. , Fahr, A., & Maurer, G. (1990). Pharmacokinetics of cyclosporine: Inter and intra-individual variations and metabolic pathways. Transplantation Proceedings, 22, 1110-1112.
27.
McAleer, M. J. , Copeland, J., Fuller, J., & Copeland, J. G. (1985). Psychological aspects of heart transplantation. Journal of Heart Transplantation, 4, 232-233.
28.
Meichenbaum, D. , & Turk, D. C. (1987). Treatment adherence: Terminology, incidence, and conceptualization. In D. Meichenbaum & D. C. Turk (Eds.), Facilitating treatment adherence: A practitioner's guide book (pp. 19-40). New York: Plenum.
29.
Meyendorf, R. , Dassing, M., Scherer, J., Klinner, B., Kemkes, B., & Reichart, B. (1989). Pridiktive und rehabilitative Gesichtspunkte bei Herztransplantierten [Predictive and rehabilitative issues in heart transplant recipients]. Herz, 14, 308-321.
30.
Olivieri, N. F. , Matsui, D., Hermann, C., & Koren, G. (1991). Compliance assessed by the Medication Event Monitoring System. Archives of Disease in Childhood, 66, 1399-1402.
31.
Podell, R. N. , & Gary, L. R. (1976). Compliance: A problem in medical management. American Family Physician, 13, 74-80.
32.
Rand, C. S. , & Wise, R. A. (1994). Measuring adherence to asthma medication regimens. American Journal of Respiratory Critical Care Medicine, 149, S69-S76.
33.
Rovelli, M. , Palmeri, D., Vossler, E., Bartus, S., Hull, D., & Schweitzer, R. (1989). Noncompliance in organ transplant recipients. Transplantation Proceedings, 21, 833-834.
34.
Rudd, P. (1979). In search of the gold standard for compliance measurement. Archives of Internal Medicine, 139, 627-628.
35.
Rudd, P. , Byyny, R. L., Zachary, V., Lo Verde, M. E., Mitchell, W. D., Titus, C., & Marchall, G. (1988). Pill count measures of compliance in a drug trial: Variability and suitability. American Journal of Hypertension, 1, 309-312.
36.
Ruygrok, P. N. , Agnew, T. M., Coverdale, H. A., Whitfield, C., & Lambie, N. K. (1994). Survival after heart transplantation without regular immunosuppression. Journal of Heart and Lung Transplantation, 13, 208-211.
37.
Sackett, D. L. , & Snow, J. C. (1979). The magnitude of compliance and noncompliance. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care (pp. 11-45). Baltimore: John Hopkins University Press.
38.
Shapiro, P. A. , Williams, D. L., Foray, A. T., Gelman, I. S., Wukich, N., & Sciacca, R. (1995). Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation, 60, 1462-1466.
39.
Steele, D. J. , Jackson, T. C., & Gutmann, M. C. (1990). Have you been taking your pill? The adherence-monitoring sequence in the medical interview. Journal of Family Practice, 30, 294-299.
40.
Sullivan, S. D. , Kreling, D. H., & Hazlet, T. K. (1990). Noncompliance withmedicationregimens and subsequent hospitalizations: A literature analysis and cost of hospitalization estimate. Journal of Research in Pharmaceutical Economics, 2, 19-33.
41.
Troppmann, C. , Benedetti, E., Gruessner, R.W.C., Payne, W. D., Sutherland, D.E.R., Najarian, J. S., & Matas, A. J. (1995). Retransplantation after renal allograft loss due to noncompliance: Indications, outcome, and ethical concerns. Transplantation, 59, 467-471.
42.
Urquhart, J. (1989). Non-compliance: The ultimate absorption barrier. In L. F. Prescott & W. S. Nimmo (Eds.), Novel drug delivery and its applications (pp. 127-137). New York: John Wiley.
43.
Urquhart, J. (1991). Patientcompliance as an exploratory variable in four selected cardiovascular studies. In J. A. Cramer & B. Spilker (Eds.), Patient compliance in medical practice and clinical trials (pp. 301-329). New York: Raven.
44.
Vander Stichele, R. (1991). Measurement of patient compliance and the interpretation of randomized clinical trials. European Journal of Clinical Pharmacology, 41, 27-35.
45.
Witenberg, S. H. , Blanchard, E. B., McCoy, G., Suls, J., & McGoldrick, M. D. (1983). Evaluation of compliance in home and center hemodialysis patients. Health Psychology, 2, 227-237.
